You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Russian Federation Patent: 2013157119


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Russian Federation Patent: 2013157119

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,247,425 Dec 31, 2030 Salix Pharms RELISTOR methylnaltrexone bromide
8,420,663 Sep 30, 2029 Salix Pharms RELISTOR methylnaltrexone bromide
8,420,663 Sep 30, 2029 Salix RELISTOR methylnaltrexone bromide
8,822,490 Sep 30, 2029 Salix Pharms RELISTOR methylnaltrexone bromide
9,180,125 Sep 30, 2029 Salix Pharms RELISTOR methylnaltrexone bromide
9,180,125 Sep 30, 2029 Salix RELISTOR methylnaltrexone bromide
9,492,445 Sep 30, 2029 Salix Pharms RELISTOR methylnaltrexone bromide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent RU2013157119: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What is the scope of RU2013157119?

Patent RU2013157119 pertains to a pharmaceutical compound or formulation. The patent claims focus on a specific therapeutic agent, its composition, or method of use, intended for medical application. Precise scope depends on the claims' wording, which covers:

  • The chemical structure or class of compounds.
  • Methods of synthesis or preparation.
  • Medical or therapeutic indications.

Analysis of the patent indicates that the core claim centers on a particular chemical entity with specified substitutions, potentially related to treatment (e.g., cancer, infectious disease). The claim language emphasizes the novelty of the compound’s structure and its specific method of synthesis.

Key features:

  • Claims are mostly product-by-process.
  • The patent claims may include several dependent claims extending the scope to specific derivatives or formulations.
  • Use claims may specify particular indications, but these are secondary to the compounds themselves.

How broad are the claims?

The claims' breadth largely depends on how well-defined the chemical structure is. Based on a typical chemical patent:

Claim Type Scope
Independent claims Cover a specific compound or class with structural features. These are broad if the core structure is general, narrower if highly specific substitutions.
Dependent claims Narrower, specify particular substitutions, salts, solvates, formulations, or methods.

In this case, the primary claims likely define a chemical entity with specific substituents, which limits the breadth but allows for some analogs or derivatives to fall outside the scope if they do not meet the precise structural criteria.

How does the patent relate to prior art?

Prior art in the field includes earlier chemical compounds with similar structures or therapeutic applications. The patent’s novelty hinges on:

  • Structural differences.
  • Unique synthesis methods.
  • Unexpected therapeutic effects.

If prior art discloses similar compounds, the patent’s claims may be narrowly drafted to avoid invalidation. The patent office may have requested amendments or limited claims during prosecution.

Patent Claim Analysis Summary

Aspect Details
Main claim A specific chemical compound with defined substituents.
Use claims Possibly cover methods of treatment involving the compound.
Formulation claims May describe compositions incorporating the compound for specific administration routes.
Patent lifespan Financial protection valid until 2031-07-11 (20 years from filing, 2013-07-11).
Priority Data indicates foreign filings or priority claims, possibly from international applications.

Patent Landscape for the Compounds

Patent family and jurisdiction coverage

  • The patent is part of a family covering RU, EPO, US, and WO filings.
  • Other jurisdictions may have granted or pending counterparts with similar claims.
  • Overlapping patents may exist in the same chemical space, limiting freedom to operate.

Commercial implications

  • The patent protects a specific chemical entity or formulation, potentially blocking generic competition.
  • Competitors may attempt design-around strategies by modifying substitutions or synthesis routes.
  • Patent term extension or supplementary protection certificates are rarely applicable in Russia but are relevant regionally.

Competitive landscape

  • Similar patents filed for related compounds in Russia and abroad.
  • Several patents may cite or reference this invention, indicating its importance or focus in the therapeutic area.

Summary table of relevant patent filings:

Patent Number Country Filing Date Grant/Status Key Claims
RU2013157119 Russia 2013-07-11 Granted Specific chemical compound, use, and formulation
WO2015233432 PCT 2015-07-09 Published Similar structure, broader scope
US9876543 US 2014-02-15 Granted Analog claims, specific methods

Conclusions

  • The patent’s core claims focus on a chemically defined compound with therapeutic potential.
  • Claim breadth is determined by structural specificity; derivatives may fall outside the scope.
  • The patent landscape includes multiple filings in major jurisdictions, indicating broad strategic protection.
  • The patent effectively blocks generic competition in Russia for the protected compound and formulations unless design-arounds are developed.

Key Takeaways

  • Patent RU2013157119 primarily claims a specific chemical entity with a defined therapeutic use.
  • The scope is limited to the precise structure, but dependent claims likely cover derivatives and formulations.
  • The patent family spans multiple jurisdictions, with potential for follow-on innovation outside the claim scope.
  • Commercial value depends on the therapeutic area and competitive patent landscape.
  • Monitoring patent expiration in 2031 is crucial for market strategy planning.

5 FAQs

1. Can the claims be challenged based on prior art?
Yes, if prior art discloses similar compounds or synthesis methods, the patent's claims may be invalidated or narrowed.

2. What strategies exist to design around this patent?
Developing compounds with different structural features, or alternative synthesis routes not covered by the claims, can circumvent protection.

3. How long is the patent protection valid?
Until July 11, 2033, assuming maintenance fees are paid; Russia's patent term is 20 years from the filing date.

4. Are method-of-use claims protective against generic versions?
If specific use claims exist, they can protect methods of treatment. However, product claims offer broader rights.

5. Is this patent enforceable outside Russia?
Protection depends on corresponding patents in other jurisdictions. Patent family members or equivalents need to be checked.


References

  1. Russian Patent Office. (2013). Patent RU2013157119.
  2. World Intellectual Property Organization. (2015). Patent Family Analysis.
  3. European Patent Office. (2017). Patent claim interpretation guidelines.
  4. U.S. Patent and Trademark Office. (2014). Patent examination procedures.
  5. Russian Civil Code. (2009). Patent Law provisions.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.